Today's News: Middle East: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today's News: Middle East.

Press releases published on November 4, 2026

Nov. 4, 2026

Auckland Mayor Joins Egyptian Officials at 2026 Global Mayors Dialogue in Ningbo

Indeterminate EIN Presswire

Nov. 4, 2026

Errachidia Mayor Joins 2026 Global Mayors Dialogue in Ningbo

Indeterminate EIN Presswire

Nov. 4, 2026

Teksan Provides Merkez Ankara with 57 MW Power Infrastructure

Indeterminate EIN Presswire

Nov. 4, 2026

Senior Physiotherapist Marcos Jusdado joins Kinesis Clinic in Dubai

Indeterminate EIN Presswire

Nov. 4, 2026

SUMEC-ITC Brings Equipment Sourcing and Trade Services to the 140th Canton Fair

Indeterminate EIN Presswire

Nov. 4, 2026

SUMEC BUILDING MATERIAL Concludes the 140th Canton Fair with Strong Global Demand for Green Building Materials

Indeterminate EIN Presswire

Nov. 4, 2026

"إكس أس دوت كوم" تعيّن هانا لي مديرةً إقليمية لتطوير الأعمال في فيتنام

Indeterminate EIN Presswire

Nov. 4, 2026

Ichnos Glenmark Innovation (IGI) to Present Updated Clinical Data for ISB 2001 (ABBV-2001) in Relapsed/Refractory Multiple Myeloma at 68th ASH Annual Meeting

Indeterminate GlobeNewswire

Nov. 4, 2026

Weebit Nano launches Weebit Matrix™ In-Memory Compute Research Program

Indeterminate GlobeNewswire

Nov. 4, 2026

High-Grade Gold Near Surface at Duquesne West Including 7.0 g/t over 24.8 m

Indeterminate GlobeNewswire

Nov. 4, 2026

ORYZON to Present Updated Positive Clinical Data for Iadademstat in Hematological Malignancies at ASH 2026

Indeterminate GlobeNewswire

Nov. 4, 2026

Translational Data from Anal Cancer Patients Show Pelareorep Drives HPV-Specific Immune Responses, Supporting its Potential Across HPV-Driven Cancers

Indeterminate GlobeNewswire

Nov. 4, 2026

Solu Therapeutics to Present Initial Phase 1 Results of STX-0712 and New Preclinical Data on STX-0640 in Two Oral Presentations at the 2026 ASH Annual Meeting

Indeterminate GlobeNewswire

Nov. 4, 2026

Lyell Immunopharma Announces $80 Million Private Placement to Advance Ronde-Cel Toward Planned BLA Submission

Indeterminate GlobeNewswire

Nov. 4, 2026

Corvus Pharmaceuticals Announces Initial Data from Soquelitinib Clinical Trial in Patients with Autoimmune Lymphoproliferative Syndrome (ALPS) will be Presented at the 68ᵗʰ American Society for Hematology Annual Meeting & Exposition

Indeterminate GlobeNewswire

Nov. 4, 2026

Secura Bio Announces Two Duvelisib Presentations on Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma at the 2026 American Society of Hematology Annual Meeting

Indeterminate GlobeNewswire

Nov. 4, 2026

Agios to Highlight Strength and Differentiation of Rare Hematology Portfolio with New Clinical Data for Mitapivat in Sickle Cell Disease and AG-236 in Polycythemia Vera at ASH 2026

Indeterminate GlobeNewswire

Nov. 4, 2026

Lyell Immunopharma to Present Positive Updated Ronde-Cel Data in More than 80 Patients at ASH 2026 from PiNACLE Pivotal Trial in 3L+ and from Phase 1/2 2L Cohort in Patients with Relapsed/Refractory Large B-Cell Lymphoma

Indeterminate GlobeNewswire

Nov. 4, 2026

SELLAS Life Sciences to Present Positive Phase 2 Data Demonstrating Encouraging Response and Survival Outcomes with SLS009 Combination in High-Risk AML at ASH 2026

Indeterminate GlobeNewswire

Nov. 4, 2026

Peer-Reviewed Scientific Journal Publishes U.S. Clinical Study Reporting Interim Results of 87.7% Accuracy for IR-MED’s PressureSafe™ Technology in Pressure-Injury Assessment

Indeterminate GlobeNewswire